Samuel Douglas, MD
Surgical Oncology · Mountain Brk, ALNPI 1811308257
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.3%), travel and lodging and education — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 63.5% of it on its own, with 28 other manufacturers making up the rest.
Across 51 payments — averaging $112.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$4K
- Boston Scientific$281
- Histosonics, Inc.$225
- Medtronic$153
- Davol Inc.$148
- Kerecis Limited$144
- plus $1K from 23 others
What the payments were for
- Speaking & faculty fees$4508%
- Travel & lodging$1,42525%
- Food & beverage$2,76748%
- Education$1,00017%
- Gifts$912%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 17 | $3,639 |
| Boston Scientific | 2 | $281 |
| Histosonics, Inc. | 1 | $225 |
| Medtronic | 1 | $153 |
| Davol Inc. | 1 | $148 |
| Kerecis Limited | 1 | $144 |
| Johnson & Johnson(2 entities) | 2 | $133 |
| W. L. Gore & Associates, Inc. | 1 | $133 |
| Conmed Corporation | 1 | $105 |
| Springworks Therapeutics, Inc. | 1 | $87 |
| Osiris Therapeutics Inc. | 1 | $79 |
| Sobi, Inc | 2 | $72 |
| Stryker | 1 | $68 |
| TELA Bio, Inc. | 1 | $50 |
| AstraZeneca | 2 | $46 |
| Lemaitre Vascular, Inc. | 1 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Merck | 1 | $34 |
| Genentech USA, Inc. | 2 | $34 |
| Novartis | 1 | $30 |
| Incyte Corporation | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Beigene USA, Inc. | 1 | $24 |
| Octapharma USA, Inc. | 1 | $23 |
| Beone Medicines USA, Inc. | 1 | $23 |
| Virtual Incision Corporation | 1 | $21 |
| Eisai Inc. | 1 | $20 |
| Adaptive Biotechnologies Corporation | 1 | $16 |
| Fennec Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,733 in reported general payments places this provider in the 80th percentile of 26 surgical oncology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in Mountain Brk
- Sophie DreamBirmingham$39K
- John HowardMobile$20K
- Annabelle FonsecaBirmingham$10K
- Katelin HolmesMontgomery$6K
- Joe LilesMobile$4K
- Udai SibiaMobile$3K
- John RoseBirmingham$3K
- Natalie BathMobile$2K
- Mercy JimenezMobile$2K
- Martin HeslinMobile$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.